Trimethylamine-N-oxide (TMAO) and clinical outcomes in patients with end-stage kidney disease receiving peritoneal dialysis.

Dongyuan ChangXiao XuZhi-Kai Yang Tian-Tian MaJing NieJie Dong

Published in: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (2021)

Serum TMAO concentration is associated with the risk of first-episode peritonitis and CVD mortality in PD patients. No obvious association between serum TMAO and all-cause mortality was observed.

Keyphrases

end stage renal disease
peritoneal dialysis
chronic kidney disease
newly diagnosed
ejection fraction
cardiovascular events
risk factors
type diabetes
patient reported